GGrantIndex
← Leaderboards

Thomas B Hildebrandt

Icahn School Of Medicine At Mount Sinai

Google Scholar ↗PubMed ↗ORCID ↗
$10,328,843
Attributed
$13,230,659
Total exposure
11
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY2007–25
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,230,659 · 11

By mechanism

R01$6,873,293 · 3
R21$1,854,055 · 3
R42$1,500,000 · 1
R44$1,264,817 · 1
K23$884,550 · 1
R41$674,008 · 1

Top collaborators

Others in their field

Top investigators on “Behavioral”

Research focus

BehavioralBehaviorWeightBaseResponseEatingImpairmentDesignEating DisordersMediatingLearningFoodInterestEating BehaviorTrainingCuesLinkBrainLaboratoriesSocialTheoriesPerformancePharmaceutical PreparationsHormonal

Grant awards (36)

A Confirmatory Efficacy Study of Interoceptive Exposure for Adolescents with Low Weight Eating Disorders$782,443
R01 · FY2025 · MH · contact PI
A Confirmatory Efficacy Study of Interoceptive Exposure for Adolescents with Low Weight Eating Disorders$782,443
R01 · FY2024 · MH · contact PI
General Brain Arousal and Risk for Eating Disorder$401,165
R01 · FY2024 · MH
A Confirmatory Efficacy Study of Interoceptive Exposure for Adolescents with Low Weight Eating Disorders$786,153
R01 · FY2023 · MH · contact PI
General Brain Arousal and Risk for Eating Disorder$401,165
R01 · FY2023 · MH
General Brain Arousal and Risk for Eating Disorder$416,484
R01 · FY2022 · MH
General Brain Arousal and Risk for Eating Disorder$434,125
R01 · FY2021 · MH
Brain Aromatase and Inhibitory Control in Bulimia Nervosa$468,179
R21 · FY2020 · MH · contact PI
Reward Systems and Food Avoidance in Adolescents with Low Weight Eating Disorders$220,916
R01 · FY2020 · MH · contact PI
Molecular Endocannabinoid Mediators of Impaired Aversive Learning in Low Weight Eating Disorders$205,015
R21 · FY2020 · MH · contact PI
Reward Systems and Food Avoidance in Adolescents with Low Weight Eating Disorders$623,091
R01 · FY2019 · MH · contact PI
Noom Coach for Bariatric Surgery$486,357
R44 · FY2019 · DK
Molecular Endocannabinoid Mediators of Impaired Aversive Learning in Low Weight Eating Disorders$262,843
R21 · FY2019 · MH · contact PI
Administrative Supplement Program to Enable Continuity of Research Experiences for Trevor Griffen, MD, PhD during Clinical Training$125,493
R01 · FY2019 · MH · contact PI
Reward Systems and Food Avoidance in Adolescents with Low Weight Eating Disorders$44,089
R01 · FY2019 · MH · contact PI
Reward Systems and Food Avoidance in Adolescents with Low Weight Eating Disorders$598,223
R01 · FY2018 · MH · contact PI
Noom Coach for Bariatric Surgery$553,460
R44 · FY2018 · DK
Reward Systems and Food Avoidance in Adolescents with Low Weight Eating Disorders$594,157
R01 · FY2017 · MH · contact PI
Noom Coach for Bariatric Surgery$225,000
R44 · FY2017 · DK
Reward Systems and Food Avoidance in Adolescents with Low Weight Eating Disorders$663,346
R01 · FY2016 · MH · contact PI
Noom Monitor for Binge Eating$536,206
R42 · FY2016 · MH
Noom Monitor for Binge Eating$416,116
R42 · FY2016 · MH
Noom Monitor for Binge Eating$547,678
R42 · FY2015 · MH
Innovative Use of the Noom Monitor Mobile Application for CBT-GSH in Binge Eaters$330,324
R41 · FY2014 · MH · contact PI
Brain aromatase availability in steroid users: PET studies with [11C]vorozole$274,783
R21 · FY2014 · DA · contact PI
Innovative Use of the Noom Monitor Mobile Application for CBT-GSH in Binge Eaters$343,684
R41 · FY2013 · MH · contact PI
Brain aromatase availability in steroid users: PET studies with [11C]vorozole$275,508
R21 · FY2013 · DA · contact PI
Brain aromatase availability in steroid users: PET studies with [11C]vorozole$64,442
R21 · FY2013 · DA · contact PI
Brain aromatase availability in steroid users: PET studies with [11C]vorozole$303,285
R21 · FY2012 · DA · contact PI
Bio-behavioral Consequences of Appearance and Performance Enhancing Drug Use$176,958
K23 · FY2012 · DA · contact PI
Bio-behavioral Consequences of Appearance and Performance Enhancing Drug Use$176,958
K23 · FY2011 · DA · contact PI
Bio-behavioral Consequences of Appearance and Performance Enhancing Drug Use$176,958
K23 · FY2010 · DA · contact PI
Bio-behavioral Consequences of Appearance and Performance Enhancing Drug Use$176,958
K23 · FY2009 · DA · contact PI
Bio-behavioral Consequences of Appearance and Performance Enhancing Drug Use$176,718
K23 · FY2008 · DA · contact PI
Assessment of Appearance and Performance Enhancing Drug Use$89,297
R03 · FY2008 · DA · contact PI
Assessment of Appearance and Performance Enhancing Drug Use$90,639
R03 · FY2007 · DA · contact PI